Learn more about the latest industry news and insights, along with Zeta India’s announcements, events, initiatives, and more — all in one place.
Learn more about the latest industry news and insights, along with Zeta India’s announcements, events, initiatives, and more — all in one place.
Category
What to look for – and how to avoid common pitfalls in greenfield and brownfield facilities Whether you are building a new biopharma facility from the ground up or upgrading an existing one, the choice
India’s biopharmaceutical industry is entering a new phase of expansion. Beyond its established leadership in vaccines and biosimilars, the country is now investing across advanced modalities, including monoclonal antibodies, cell and gene therapies, plasma products,
What does it take to scale large-scale biopharmaceutical production fast without sacrificing compliance, robustness, or product quality? In this case study, see how a globally recognised vaccine manufacturer executed a major capacity expansion (new bioreactor
Sustainability is no longer a side conversation in the pharmaceutical industry — it is becoming a core design principle. As global demand for medicines rises and manufacturing scales up, the environmental footprint of pharma production
Advancing Simulation-Driven Engineering In February 2026, ZETA India connected with industry professionals through a focused roadshow in Hyderabad (03 Feb) and Bengaluru (05 Feb), bringing simulation-led innovation closer to customers and partners. The events saw
India’s pharmaceutical manufacturing sector is experiencing rapid growth, reinforcing its position as the “pharmacy of the world.” According to the EY-Parthenon–OPPI report, pharma exports reached $27.85 billion in FY 2023–24, nearing the $30 billion mark.
The global fermenters market reached $1.80 billion in 2025 and is projected to reach $2.63 billion by 2032 at a 5.60% CAGR, driven by rising biopharma demand for vaccines, biosimilars, and recombinant proteins. In the
In the highly regulated and complex pharma and biotech sectors, fragmented engineering processes often lead to costly delays, compliance issues, and inefficient facilities that hinder production scale-up. Project managers, production heads, and CEOs need a
After the founders closed their seed round for a biotech startup, it felt like the hardest part was behind them. The upstream platform for a new class of recombinant proteins had worked beautifully in the
A simulation-first approach is quickly becoming non‑negotiable in biopharma facilities – both greenfield and brownfield projects. It is one of the few levers that can simultaneously de‑risk capex, compress timelines and stabilise operations over a
As production leaders in biopharma companies, you will appreciate the complex journey from bench-scale research to full-scale GMP manufacturing. At ZETA, we know first-hand that scaling up a bioreactor process is never simply a matter
Fermentation is the backbone of contemporary biopharmaceutical production, enabling manufacturers to create a wide range of products, from life-saving vaccines to high-value APIs and recombinant proteins. For production and project managers, mastering the principles of
On April 8, 2025, ZETA India had the honor of welcoming a delegation of Chemical Engineering students from Ramaiah Institute of Technology, Bengaluru, to our facility. The primary aim of the visit was to provide
ZETA India is delighted to announce the successful completion of the 4th batch of our Industrial Training Programme on Training in Biopharma Equipment. We extend our heartfelt congratulations to our trainees — Sanath Kumar P,
ZETA India is pleased to announce the successful completion of our first six-month training programme on Bioprocess Engineering – Design and Operation of Bioprocess Equipment. This achievement marks a significant milestone in our ongoing commitment
The biopharmaceutical market in the Asian region shows enormus growth potential. The internationally active ZETA Group has established itself as an end-to-end solution. ZETA Biosystem aims to improve its integration into the international ZETA Group
What does it take to scale large-scale biopharmaceutical production fast without sacrificing compliance, robustness, or product quality? In this case study, see how a globally recognised vaccine manufacturer executed a major capacity expansion (new bioreactor
As production leaders in biopharma companies, you will appreciate the complex journey from bench-scale research to full-scale GMP manufacturing. At ZETA, we know first-hand that scaling up a bioreactor process is never simply a matter
Driving Global Readiness in Indian Pharma: ZETA India’s Roadmap for Annex 1 Compliance and FDA’s Aseptic Guidance India’s pharmaceutical sector stands at a global inflexion point. Renowned as the world’s pharmacy, the nation’s sterile manufacturing
What to look for – and how to avoid common pitfalls in greenfield and brownfield facilities Whether you are building a new biopharma facility from the ground up or upgrading an existing one, the choice
India’s biopharmaceutical industry is entering a new phase of expansion. Beyond its established leadership in vaccines and biosimilars, the country is now investing across advanced modalities, including monoclonal antibodies, cell and gene therapies, plasma products,
Sustainability is no longer a side conversation in the pharmaceutical industry — it is becoming a core design principle. As global demand for medicines rises and manufacturing scales up, the environmental footprint of pharma production
India’s pharmaceutical manufacturing sector is experiencing rapid growth, reinforcing its position as the “pharmacy of the world.” According to the EY-Parthenon–OPPI report, pharma exports reached $27.85 billion in FY 2023–24, nearing the $30 billion mark.
The global fermenters market reached $1.80 billion in 2025 and is projected to reach $2.63 billion by 2032 at a 5.60% CAGR, driven by rising biopharma demand for vaccines, biosimilars, and recombinant proteins. In the
In the highly regulated and complex pharma and biotech sectors, fragmented engineering processes often lead to costly delays, compliance issues, and inefficient facilities that hinder production scale-up. Project managers, production heads, and CEOs need a
After the founders closed their seed round for a biotech startup, it felt like the hardest part was behind them. The upstream platform for a new class of recombinant proteins had worked beautifully in the
A simulation-first approach is quickly becoming non‑negotiable in biopharma facilities – both greenfield and brownfield projects. It is one of the few levers that can simultaneously de‑risk capex, compress timelines and stabilise operations over a
Fermentation is the backbone of contemporary biopharmaceutical production, enabling manufacturers to create a wide range of products, from life-saving vaccines to high-value APIs and recombinant proteins. For production and project managers, mastering the principles of
Selecting the Right Agitator: What Matters Most for Pharma Procurement and Project Teams ZETA Magnetic Agitators: A Versatile, Proven Product Family At the core of ZETA’s offering is an impressive portfolio of magnetic agitators, including
For procurement heads and project managers in the pharmaceutical industry, few choices are as consequential as selecting the right mixer or agitator supplier. At the heart of every bioreactor and process vessel, the agitator must
Advancing Simulation-Driven Engineering In February 2026, ZETA India connected with industry professionals through a focused roadshow in Hyderabad (03 Feb) and Bengaluru (05 Feb), bringing simulation-led innovation closer to customers and partners. The events saw
The spirit of tradition, unity, and gratitude filled the atmosphere as ZETA India – Unit 1 joyfully celebrated Ayudha Pooja 2025 with great enthusiasm. This significant occasion honors the tools, machines, and technologies that enable
We are pleased to have been a part of Pharma Pro & Pack 2025 in Hyderabad, where ZETA India showcased its latest innovations in the biopharma and pharma sectors. During the event, ZETA highlighted its
ZETA India is pleased to report the successful conclusion of an industrial visit by 45 biotechnology students from B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, which took place on Tuesday, 22nd October
We work closely with biopharmaceutical organizations to deliver reliable, precise, and high-quality bioprocess engineering solutions.
